Publications by authors named "Minerva Batugo"

Claim this Profile
I
Intraocular Pressure-Lowering Activity of NCX 470, a Novel Nitric Oxide-Donating Bimatoprost in Preclinical Models.
Francesco Impagnatiello, Carol B Toris, Minerva Batugo, Ganesh Prasanna, Valentina Borghi

Invest Ophthalmol Vis Sci· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular differentiation of imatinib and bosutinib in the rat.
Jonathan R Heyen, Wenyue Hu, Joseph Jamieson, Stephane Thibault, Minerva Batugo

Int J Hematol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery pharmacokinetic studies in mice using serial microsampling, dried blood spots and microbore LC-MS/MS.
Sadayappan V Rahavendran, Sylvia Vekich, Heather Skor, Minerva Batugo, Leslie Nguyen

Bioanalysis· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma.
Valentina Borghi, Elena Bastia, Massimiliano Guzzetta, Valerio Chiroli, Carol B Toris, Minerva R Batugo

J Ocul Pharmacol Ther· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of human corneal epithelial cell model as a surrogate for corneal permeability assessment: metabolism and transport.
Cathie D Xiang, Minerva Batugo, David C Gale, Tao Zhang, Jingjing Ye

Drug Metab Dispos· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of novel nitric oxide (NO)-releasing esters of timolol.
Valerio Chiroli, Minerva R Batugo, Stefano Biondi, Annalisa Bonfanti, Stefania Brambilla

Bioorg Med Chem Lett· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics.
Peter S Dragovich, Thomas J Prins, Ru Zhou, Theodore O Johnson, Ye Hua, Minerva R Batugo

J Med Chem· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics.
Peter S Dragovich, Thomas J Prins, Ru Zhou, Edward L Brown, Fausto C Maldonado, Minerva R Batugo

J Med Chem· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis